Sudeep Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 1.50 per equity share.
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudeep Pharma's Board of Directors has recommended a final dividend of Rs. 1.50 per equity share (150% on face value of Rs. 1 each) for the year ended 31 March 2026, subject to shareholder approval at the AGM. The company reported strong consolidated performance with revenue from operations growing 28% to Rs. 64,225.80 lakhs and profit after tax rising 25.6% to Rs. 17,428.47 lakhs compared to the previous year. EPS stood at Rs. 15.50. The company recently completed its IPO in November 2025, raising Rs. 8,833.59 lakhs in net proceeds which are being deployed towards capital expenditure and general corporate purposes. The Board also approved appointments of cost and secretarial auditors for the new financial year.
The recommended dividend signals healthy cash generation and reflects strong financial performance post-IPO. For shareholders, this represents a positive return, though the dividend yield remains modest relative to the IPO issue price of Rs. 593 per share.